The Bluetongue virus serotype 8 (BTV-8) strain, which emerged in Europe in 2006, had an unusually high ability to cause foetal infection in pregnant ruminants. Other serotypes of BTV had already been present in Europe for more than a decade, but transplacental transmission of these strains had never been demonstrated. To determine whether transplacental transmission is a unique feature of BTV-8 we compared the incidence and pathological consequences of transplacental transmission of BTV-8 to that of BTV-1. Nine pregnant ewes were infected with either BTV-8 or BTV-1. The BTV strains used for the infection were field strains isolated on embryonated chicken eggs and passaged twice on mammalian cells. Blood samples were taken to monitor the viraemia in the ewes. Four weeks after the infection, the foetuses were examined for pathological changes and for the presence of BTV. BTV-8 could be demonstrated in 12 foetuses (43%) from 5 ewes (56%). %). BTV-1 was detected in 14 foetuses (82%) from 6 ewes (67%). Pathological changes were mainly found in the central nervous system. In the BTV-8 group, lympho-histiocytic infiltrates, gliosis and slight vacuolation of the neuropil were found. BTV-1infection induced a severe necrotizing encephalopathy and severe meningitis, with macroscopic hydranencephaly or porencephaly in 8 foetuses. In our experimental setting, using low passaged virus strains, BTV-1 was able to induce transplacental transmission to a higher incidence compared to BTV-8, causing more severe pathology.
References
[1]
Darpel KE, Batten CA, Veronesi E, Shaw AE, Anthony S, et al. (2007) Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe. Vet Rec 161: 253–261.
[2]
Dal Pozzo F, Saegerman C, Thiry E (2009) Bovine infection with bluetongue virus with special emphasis on European serotype 8. Vet J 182: 142–151.
[3]
Roy P (2008) Functional mapping of bluetongue virus proteins and their interactions with host proteins during virus replication. Cell Biochem Biophysics 50: 143–157.
[4]
Ratinier M, Caporale M, Golder M, Franzoni G, Allan K, et al. (2011) Identification and characterization of a novel non-structural protein of bluetongue virus. PLoS Pathog 7 art no e1002447.
[5]
Hofmann MA, Renzullo S, Mader M, Chaignat V, Worwa G, et al. (2008) Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland. Emerg Infect Dis 14: 1855–1861.
[6]
Maan S, Maan NS, Nomikou K, Batten C, Antony F, et al. (2011) Novel bluetongue virus serotype from Kuwait. Emerg Infect Dis 17: 886–889.
[7]
Gould AR, Pritchard LI (1990) Relationships amongst bluetongue viruses revealed by comparisons of capsid and outer coat protein nucleotide sequences. Virus Res 17: 31–52.
[8]
Gould AR (1987) The complete nucleotide sequence of bluetongue virus serotype 1 RNA3 and a comparison with other geographic serotypes from Australia, South Africa and the United States of America, and with other orbivirus isolates. Virus Res 7: 169–183.
[9]
Shaw AE, Ratinier M, Nunes SF, Nomikou K, Caporale M, et al. (2013) Reassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segment. J Virol 87: 543–557.
[10]
Maan S, Maan NS, Van Rijn PA, van Gennip RGP, Sanders O, et al. (2010) Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains. PLoS ONE 5 art no e10323.
[11]
Maan NS, Maan S, Nomikou K, Guimera M, Pullinger G, et al. (2012) The genome sequence of bluetongue virus type 2 from India: Evidence for reassortment between eastern and western topotype field strains. J Virol 86: 5967–5968.
[12]
Waldvogel AS, Anderson CA, Higgins RJ, Osburn BI (1987) Neurovirulence of the UC-2 and UC-8 strains of bluetongue virus serotype 11 in newborn mice. Vet Pathol 24: 404–410.
[13]
Saegerman C, Bolkaerts B, Baricalla C, Raes M, Wiggers L, et al. (2011) The impact of naturally-occurring, trans-placental bluetongue virus serotype-8 infection on reproductive performance in sheep. Vet J 187: 72–80.
[14]
Santman-Berends IMGA, Hage JJ, Van Rijn PA, Stegeman JA, van Schaik G (2010) Bluetongue virus serotype 8 (BTV-8) infection reduces fertility of Dutch dairy cattle and is vertically transmitted to offspring. Theriogenology 74: 1377–1384.
[15]
Shultz G, DeLay P (1955) Losses in newborn lambs associated with bluetongue vaccination of pregnant ewes. J Am Vet Med Assoc 127: 224–226.
[16]
Anderson CK, Jensen R (1969) Pathologic changes in placentas of ewes inoculated with bluetongue virus. Am J Vet Res 30: 987–989.
[17]
Jochim MM, Luedke AJ, Chow TL (1974) Bluetongue in cattle: immunogenic and clinical responses in calves inoculated in utero and after birth. Am J Vet Res 35: 517–522.
[18]
Luedke AJ, Jochim MM, Jones RH (1977) Bluetongue in cattle: effects of Culicoides variipennis-transmitted bluetongue virus on pregnant heifers and their calves. Am J Vet Res 38: 1687–1695.
[19]
MacLachlan NJ, Osburn BI, Ghalib HW, Stott JL (1985) Bluetongue virus-induced encephalopathy in fetal cattle. Vet Pathol 22: 415–417.
[20]
Flanagan M, Johnson SJ (1995) The effects of vaccination of Merino ewes with an attenuated Australian bluetongue virus serotype 23 at different stages of gestation. Aust Vet J 72: 455–457.
[21]
Flanagan M, Wilson AJ, Trueman KF, Shepherd MA (1982) Bluetongue virus serotype 20 infection in pregnant Merino sheep. Aust Vet J 59: 18–20.
[22]
MacLachlan NJ, Conley AJ, Kennedy PC (2000) Bluetongue and equine viral arteritis viruses as models of virus-induced fetal injury and abortion. Anim Reprod Sci 60–61: 643–651.
[23]
Darpel KE, Batten CA, Veronesi E, Williamson S, Anderson P, et al. (2009) Transplacental transmission of bluetongue virus 8 in cattle, UK. Emerg Infect Dis 15: 2025–2028.
[24]
Savini G, Lorusso A, Paladini C, Migliaccio P, Di Gennaro A, et al. (2012) Bluetongue Serotype 2 and 9 Modified Live Vaccine Viruses as Causative Agents of Abortion in Livestock: A Retrospective Analysis in Italy. Transbound Emerg Dis In press.
[25]
Savini G, MacLachlan NJ, Sanchez-Vizcaino JM, Zientara S (2008) Vaccines against bluetongue in Europe. Comp Immunol, Microbiol Infect Dis 31: 101–120.
[26]
van der Sluijs M, Timmermans M, Moulin V, Noordegraaf CV, Vrijenhoek M, et al. (2011) Transplacental transmission of Bluetongue virus serotype 8 in ewes in early and mid gestation. Vet Microbiol 149: 113–125.
[27]
Shaw AE, Monaghan P, Alpar HO, Anthony S, Darpel KE, et al. (2007) Development and initial evaluation of a real-time RT-PCR assay to detect bluetongue virus genome segment 1. J Virol Methods 145: 115–126.
[28]
van der Sluijs MTW, Schroer-Joosten DPH, Fid-Fourkour A, Vrijenhoek MP, Debyser I, et al. (2012) Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid-term pregnant ewes and heifers. Vaccine 30: 647–655.
[29]
Osburn BI, Silverstein AM, Prendergast RA, Johnson RT, Parshall CJ Jr (1971) Experimental viral-induced congenital encephalopathies. I. Pathology of hydranencephaly and porencephaly caused by bluetongue vaccine virus. Lab Invest 25: 197–205.
[30]
Richards WPC, Cordy DR (1967) Bluetongue virus infection: Pathologic responses of nervous systems in sheep and mice. Science 156: 530–531.
[31]
Osburn BI, Johnson RT, Silverstein AM, Prendergast RA, Jochim MM, et al. (1971) Experimental viral-induced congenital encephalopathies. II. The pathogenesis of bluetongue vaccine virus infection in fetal lambs. Lab Invest 25: 206–210.
[32]
European Commission DDAH (2008) Short Report of the Working Group on bluetongue transmission and surveillance. 1–2. 30-4-2008, Brussels
[33]
Bonneau KR, Mullens BA, MacLachlan NJ (2001) Occurrence of genetic drift and founder effect during quasispecies evolution of the VP2 and NS3/NS3A genes of bluetongue virus upon passage between sheep, cattle, and Culicoides sonorensis. J Virol 75: 8298–8305.
[34]
Kirkland PD, Hawkes RA (2004) A comparison of laboratory and ‘wild’ strains of bluetongue virus - Is there any difference and does it matter? Vet Ital 40: 448–455.
[35]
Roeder PL, Taylor WP, Roberts DH, Wood L, Jeggo MH, et al. (1991) Failure to establish congenital bluetongue virus infection by infecting cows in early pregnancy. Vet Rec 128: 301–304.
[36]
Richardson C, Taylor WP, Terlecki S, Gibbs EP (1985) Observations on transplacental infection with bluetongue virus in sheep. Am J Vet Res 46: 1912–1922.
[37]
Gibbs EPJ, Lawman MJP, Herniman KAJ (1979) Preliminary observations on transplacental infection of bluetongue virus in sheep - a possible overwintering mechanism. Res Vet Sci 27: 118–120.
[38]
Backx A, Heutink R, van Rooij E, van Rijn P (2009) Transplacental and oral transmission of wild-type bluetongue virus serotype 8 in cattle after experimental infection. Vet Microbiol 138: 235–243.
[39]
Menzies FD, McCullough SJ, McKeown IM, Forster JL, Jess S, et al. (2008) Evidence for transplacental and contact transmission of bluetongue virus in cattle. Vet Rec 163: 203–209.
[40]
Batten CA, Henstock MR, Steedman HM, Waddington S, Edwards L, et al. (2012) Bluetongue virus serotype 26: Infection kinetics, pathogenesis and possible contact transmission in goats. Vet Microbiol In press.
[41]
European Commission (2013 February) Health and Consumers - Animals -Bluetongue. Available: http://ec.europa.eu/food/animal/diseases？/controlmeasures/bluetongue_en.htm. Accessed 12-2-22013.
